NCT03258229

Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Hyperglycemia

A 8-week, Randomized, Double-blind, Placebo-controlled 2x2 Cross-over Design Human Trial to Evaluate the Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Hyperglycemia

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Chonbuk National University Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 80 Years
• Healthy volunteers: Accepted

Summary

This study was conducted to investigate the effects of daily supplementation of Angelica gigas N. extract on improvement of Hyperglycemia .

Detailed description

This study was a 8 weeks, randomized, double-blind, placebo-controlled 2×2 cross-over design human trial. Twenty subjects were randomly divided into Angelica gigas N. extract or a placebo group. Fasting and postprandial glucose profiles during oral glucose tolerance test (OGTT) were assessed before and after the intervention.

Conditions

• Hyperglycemia

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Angelica gigas N. extract	capsules(2cap/d, 1,000mg/d) for 8 weeks.
DIETARY_SUPPLEMENT	Placebo	Placebo for 8 weeks

Timeline

• Start date: 2017-02-09
• Primary completion: 2017-12-07
• Completion: 2017-12-07
• First posted: 2017-08-23
• Last updated: 2019-08-22

Locations

1 site across 1 country: South Korea